Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses

Biological agents have dramatically improved treatment options for patients with severe psoriasis. Etanercept (tumor necrosis factor [TNF] receptor–immunoglobulin fusion protein) is an effective treatment for many psoriasis patients, and blockade of TNF is considered to be its primary action. Howeve...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Zaba, Lisa C., Cardinale, Irma, Gilleaudeau, Patricia, Sullivan-Whalen, Mary, Suárez-Fariñas, Mayte, Fuentes-Duculan, Judilyn, Novitskaya, Inna, Khatcherian, Artemis, Bluth, Mark J., Lowes, Michelle A., Krueger, James G.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: The Rockefeller University Press 2007
Konular:
Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2150965/
https://ncbi.nlm.nih.gov/pubmed/18039949
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1084/jem.20071094
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller